2型糖尿病患者-话题@MedSci

#2型糖尿病患者#

722篇内容 | 7277人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1383730, encodeId=5f6e1383e3032, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=DOM：达格列净联合沙格列汀和格列美脲对以二甲双胍为背景治疗的2型糖尿病患者的长期影响, objectType=article, longId=219865, objectId=809721986557, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=809721986557, replyNumber=0, likeNumber=45, createdTime=2021-11-07, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=809721986557, moduleTitle=DOM：达格列净联合沙格列汀和格列美脲对以二甲双胍为背景治疗的2型糖尿病患者的长期影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=809721986557)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383729, encodeId=82b21383e29dc, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Diabetes:恩格列净治疗通过减小心肌细胞体积改善2型糖尿病患者心脏能量和功能, objectType=article, longId=219741, objectId=84c2219e41fe, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84c2219e41fe, replyNumber=0, likeNumber=73, createdTime=2021-11-05, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84c2219e41fe, moduleTitle=Diabetes:恩格列净治疗通过减小心肌细胞体积改善2型糖尿病患者心脏能量和功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=84c2219e41fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383728, encodeId=0df01383e2821, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Diabetes Obes Metab：恩格列净对2型糖尿病患者红细胞生成的影响, objectType=article, longId=219735, objectId=d8a3219e35d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d8a3219e35d3, replyNumber=0, likeNumber=67, createdTime=2021-11-05, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d8a3219e35d3, moduleTitle=Diabetes Obes Metab：恩格列净对2型糖尿病患者红细胞生成的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d8a3219e35d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383727, encodeId=051c1383e2793, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Cardiovasc Diabetol：恩格列净对2型糖尿病患者右心室参数和功能的影响, objectType=article, longId=219696, objectId=9bf02196962f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9bf02196962f, replyNumber=0, likeNumber=72, createdTime=2021-11-04, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9bf02196962f, moduleTitle=Cardiovasc Diabetol：恩格列净对2型糖尿病患者右心室参数和功能的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9bf02196962f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383726, encodeId=af721383e26e9, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=JAHA：伴有和不伴有心衰的2型糖尿病患者肌肉交感神经活动对达格列净的反应不同, objectType=article, longId=219668, objectId=f98221966848, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f98221966848, replyNumber=0, likeNumber=76, createdTime=2021-11-04, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f98221966848, moduleTitle=JAHA：伴有和不伴有心衰的2型糖尿病患者肌肉交感神经活动对达格列净的反应不同, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f98221966848)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383725, encodeId=7dbe1383e25a3, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Antioxidants ：GLP1-RA、SGLT-2i及其联合治疗12个月对2型糖尿病患者氧化和抗氧化生物标志物的影响, objectType=article, longId=219643, objectId=0933219643a0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0933219643a0, replyNumber=0, likeNumber=87, createdTime=2021-11-03, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0933219643a0, moduleTitle=Antioxidants ：GLP1-RA、SGLT-2i及其联合治疗12个月对2型糖尿病患者氧化和抗氧化生物标志物的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0933219643a0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383724, encodeId=df291383e2411, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Diabetes Obes Metab：finerenone(非奈利酮)对GLP-1RA治疗慢性肾脏病和2型糖尿病患者的疗效和安全性, objectType=article, longId=219640, objectId=2997219640dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2997219640dc, replyNumber=0, likeNumber=81, createdTime=2021-11-03, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2997219640dc, moduleTitle=Diabetes Obes Metab：finerenone(非奈利酮)对GLP-1RA治疗慢性肾脏病和2型糖尿病患者的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2997219640dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383723, encodeId=b2611383e235a, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Clin Appl Thromb Hemost：一项Meta分析：他汀类药物治疗对2型糖尿病患者糖尿病视网膜病变的影响, objectType=article, longId=218806, objectId=6e3221880608, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e3221880608, replyNumber=0, likeNumber=73, createdTime=2021-10-20, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e3221880608, moduleTitle=Clin Appl Thromb Hemost：一项Meta分析：他汀类药物治疗对2型糖尿病患者糖尿病视网膜病变的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6e3221880608)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383722, encodeId=ee711383e2225, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Cardiovasc Diabetol：不同胰岛素抵抗替代指标对2型糖尿病患者经皮冠状动脉介入治疗后预后预测和分层的比较, objectType=article, longId=218500, objectId=c17321850023, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c17321850023, replyNumber=0, likeNumber=116, createdTime=2021-10-14, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c17321850023, moduleTitle=Cardiovasc Diabetol：不同胰岛素抵抗替代指标对2型糖尿病患者经皮冠状动脉介入治疗后预后预测和分层的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c17321850023)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383721, encodeId=05d41383e2166, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Clin Pharmacol Ther ：2型糖尿病患者中GLP-1 RA和DPP-4抑制剂的使用与肠梗阻风险增加相关, objectType=article, longId=218302, objectId=3ada21830258, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3ada21830258, replyNumber=0, likeNumber=61, createdTime=2021-10-11, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3ada21830258, moduleTitle=Clin Pharmacol Ther ：2型糖尿病患者中GLP-1 RA和DPP-4抑制剂的使用与肠梗阻风险增加相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3ada21830258)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383720, encodeId=47bc1383e2002, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=DOM：基础胰岛素联合口服药物治疗2型糖尿病患者，将基础胰岛素改为甘精胰岛素300U/mL的疗效和安全性观察, objectType=article, longId=218151, objectId=419321815137, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=419321815137, replyNumber=0, likeNumber=59, createdTime=2021-10-07, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=419321815137, moduleTitle=DOM：基础胰岛素联合口服药物治疗2型糖尿病患者，将基础胰岛素改为甘精胰岛素300U/mL的疗效和安全性观察, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=419321815137)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383719, encodeId=205b1383e19c5, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Diabetes Obes Metab：2型糖尿病患者索格列净疗效分析, objectType=article, longId=217855, objectId=913921e855ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=913921e855ab, replyNumber=0, likeNumber=57, createdTime=2021-09-30, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=913921e855ab, moduleTitle=Diabetes Obes Metab：2型糖尿病患者索格列净疗效分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=913921e855ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383718, encodeId=efc61383e187c, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Diabetes Care：注意了！2型糖尿病患者的肾脏功能检测远不达标！, objectType=article, longId=217637, objectId=917521e637ad, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=917521e637ad, replyNumber=0, likeNumber=99, createdTime=2021-09-26, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=917521e637ad, moduleTitle=Diabetes Care：注意了！2型糖尿病患者的肾脏功能检测远不达标！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=917521e637ad)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383717, encodeId=92fc1383e17d4, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=JAHA：2型糖尿病患者的钠-葡萄糖协同转运蛋白2抑制剂、全因死亡率和心血管结局, objectType=article, longId=217061, objectId=cf3921e0617e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf3921e0617e, replyNumber=0, likeNumber=79, createdTime=2021-09-15, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf3921e0617e, moduleTitle=JAHA：2型糖尿病患者的钠-葡萄糖协同转运蛋白2抑制剂、全因死亡率和心血管结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf3921e0617e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383716, encodeId=e87e1383e16ff, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Diabetologia:2型糖尿病患者长期使用二甲双胍与肺炎和相关死亡的风险相关, objectType=article, longId=216992, objectId=0b1d21699212, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0b1d21699212, replyNumber=0, likeNumber=70, createdTime=2021-09-13, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b1d21699212, moduleTitle=Diabetologia:2型糖尿病患者长期使用二甲双胍与肺炎和相关死亡的风险相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b1d21699212)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383715, encodeId=71701383e1586, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Diabetologia：利伐沙班 vs 阿司匹林可改善有高心血管风险的2型糖尿病患者的内皮功能，但会增加出血风险, objectType=article, longId=216896, objectId=0a1721689639, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a1721689639, replyNumber=0, likeNumber=90, createdTime=2021-09-11, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a1721689639, moduleTitle=Diabetologia：利伐沙班 vs 阿司匹林可改善有高心血管风险的2型糖尿病患者的内皮功能，但会增加出血风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a1721689639)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383714, encodeId=d62e1383e14ae, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Diabetologia：踝肱指数可以提示2型糖尿病患者微血管和大血管并发症的发展和预后, objectType=article, longId=216569, objectId=7bf321656964, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7bf321656964, replyNumber=0, likeNumber=65, createdTime=2021-09-03, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7bf321656964, moduleTitle=Diabetologia：踝肱指数可以提示2型糖尿病患者微血管和大血管并发症的发展和预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7bf321656964)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383713, encodeId=35ee1383e13c6, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Cardiovasc Diabetol：体重大幅度波动会增加2型糖尿病患者的心血管疾病风险！, objectType=article, longId=216453, objectId=cb092164537d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb092164537d, replyNumber=0, likeNumber=84, createdTime=2021-08-31, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb092164537d, moduleTitle=Cardiovasc Diabetol：体重大幅度波动会增加2型糖尿病患者的心血管疾病风险！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb092164537d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383712, encodeId=f0961383e12d0, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=Cardiovascular Diabetology：不同强度的联合训练对2型糖尿病患者血管产生有利影响，抓紧动起来吧！！！, objectType=article, longId=216264, objectId=01ef2162648b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=01ef2162648b, replyNumber=0, likeNumber=75, createdTime=2021-08-26, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=01ef2162648b, moduleTitle=Cardiovascular Diabetology：不同强度的联合训练对2型糖尿病患者血管产生有利影响，抓紧动起来吧！！！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=01ef2162648b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1383711, encodeId=f68c1383e1129, content=<a href='/topic/show?id=196a1101f7' target=_blank style='color:#2F92EE;'>#2型糖尿病患者#</a>, objectTitle=２型糖尿病患者中医证型分析, objectType=article, longId=216161, objectId=ed86216161fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed86216161fa, replyNumber=0, likeNumber=118, createdTime=2021-08-24, rootId=0, userName=aids213, userId=ec19483, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed86216161fa, moduleTitle=２型糖尿病患者中医证型分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed86216161fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

2型糖尿病患者

2020-05-29

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

DOM：达格列净联合沙格列汀和格列美脲对以二甲双胍为背景治疗的2型糖尿病患者的长期影响

2021-11-07

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Diabetes:恩格列净治疗通过减小心肌细胞体积改善2型糖尿病患者心脏能量和功能

2021-11-05

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Diabetes Obes Metab：恩格列净对2型糖尿病患者红细胞生成的影响

2021-11-05

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Cardiovasc Diabetol：恩格列净对2型糖尿病患者右心室参数和功能的影响

2021-11-04

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

JAHA：伴有和不伴有心衰的2型糖尿病患者肌肉交感神经活动对达格列净的反应不同

2021-11-04

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Antioxidants ：GLP1-RA、SGLT-2i及其联合治疗12个月对2型糖尿病患者氧化和抗氧化生物标志物的影响

2021-11-03

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Diabetes Obes Metab：finerenone(非奈利酮)对GLP-1RA治疗慢性肾脏病和2型糖尿病患者的疗效和安全性

2021-11-03

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Clin Appl Thromb Hemost：一项Meta分析：他汀类药物治疗对2型糖尿病患者糖尿病视网膜病变的影响

2021-10-20

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Cardiovasc Diabetol：不同胰岛素抵抗替代指标对2型糖尿病患者经皮冠状动脉介入治疗后预后预测和分层的比较

2021-10-14

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Clin Pharmacol Ther ：2型糖尿病患者中GLP-1 RA和DPP-4抑制剂的使用与肠梗阻风险增加相关

2021-10-11

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

DOM：基础胰岛素联合口服药物治疗2型糖尿病患者，将基础胰岛素改为甘精胰岛素300U/mL的疗效和安全性观察

2021-10-07

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Diabetes Obes Metab：2型糖尿病患者索格列净疗效分析

2021-09-30

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Diabetes Care：注意了！2型糖尿病患者的肾脏功能检测远不达标！

2021-09-26

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

JAHA：2型糖尿病患者的钠-葡萄糖协同转运蛋白2抑制剂、全因死亡率和心血管结局

2021-09-15

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Diabetologia:2型糖尿病患者长期使用二甲双胍与肺炎和相关死亡的风险相关

2021-09-13

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Diabetologia：利伐沙班 vs 阿司匹林可改善有高心血管风险的2型糖尿病患者的内皮功能，但会增加出血风险

2021-09-11

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Diabetologia：踝肱指数可以提示2型糖尿病患者微血管和大血管并发症的发展和预后

2021-09-03

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Cardiovasc Diabetol：体重大幅度波动会增加2型糖尿病患者的心血管疾病风险！

2021-08-31

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

Cardiovascular Diabetology：不同强度的联合训练对2型糖尿病患者血管产生有利影响，抓紧动起来吧！！！

2021-08-26

aids213 (审核中...)

前往app查看评论内容

#2型糖尿病患者#

２型糖尿病患者中医证型分析

2021-08-24

科室
- - 订阅+
  - 更多科室
工具
服务